5th Annual Pediatric Cancer Symposium
The activity provides an exceptional group of nationally and internationally-recognized experts in the field who will gather in Milwaukee to share the latest data for immunotherapy research and its relation to pediatric solid tumors.
Pediatricians, Family Practice Physicians, Nurse Practitioners and Physician Assistants.
The learner will be able to understand the rationale and circumstances for providing novel immunotherapy treatment options for their patients who have malignant disorders.
Agenda | Thursday, May 10
8:30 a.m. Registration and breakfast
9:00 a.m. Welcome by Robert Lane, MD | Children’s Hospital of Wisconsin
9:05 a.m. Overview of topic by Cindy Schwartz, MD, MPH | Children’s Hospital of Wisconsin
9:15 a.m. NK Therapy for Neuroblastoma: What's Done and What's to Come by Katharine Hsu, MD, PhD | Memorial Sloan Kettering Cancer Center
10 a.m. Engineering Lymphocytes for the Adoptive Immunotherapy of Solid Tumors by Stephen Gottschalk, MD | St. Jude Children's Research Hospital
10:45 a.m. Break and poster viewing
11:15 a.m. Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX (CAIX) in Solid Tumors by Shoukat Dedhar, PhD | University of British Columbia
12 p.m. Lunch
1 p.m. New Approaches to Treat Pediatric Cancers: Cell-Based Therapies and Beyond by Mario Otto, MD, PhD | University of Wisconsin - Madison
1:45 p.m. Cancer-Specific Mutations Targeted with Receptor-Engineered T Cells by Hans Schreiber, MD, PhD | The University of Chicago
2:30 p.m. Break
2:45 p.m. Novel Immunotherapy in Pediatric Solid Tumors by Mitchell Cairo, MD | New York Medical College
Cindy Schwartz, MD, MPH
Subramaniam Malarkannan, PhD
Monica Thakar, MD
Katharine Hsu, MD, PhD
Stephen Gottschalk, MD
Shoukat Dedhar, PhD
Mario Otto, MD, PhD
Hans Schreiber, MD, PhD
Mitchell Cairo, MD
All persons in control of content have NO relevant financial relationships to disclose except the following person(s):
Shoukat Dedhar, MD
Welichem Biotechnology, Inc.
|Mitchell Cairo, MD|
Stephen Gottschalk, MD
|Mario Otto, MD, PhD||Patents related to use of radiolabeled Alkyl Phosphocholine Anologs||Patent Holder|
In accordance with the ACME Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 4.5 hours of participation for continuing education for allied health professionals.
- 4.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.50 Hours of ParticipationHours of Participation credit.